Barclays lowered the firm’s price target on Kenvue (KVUE) to $17 from $20 and keeps an Equal Weight rating on the shares. The firm adjusted models to reflect “muted and decelerating” growth in parts of the personal care space since the Q2 reports.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KVUE:
- Kenvue Inc call volume above normal and directionally bullish
- Trump Weekly: President threatens new tariffs, announces TikTok deal
- Trump threatens new tariffs on drugs, kitchen cabinets, trucks: Morning Buzz
- Moderately bullish activity in Kenvue Inc with shares up 0.4%
- Trump tells pregnant women ‘don’t use Tylenol unless absolutely necessary’